All I am saying is that Novomatic does not need a full takeover once control is achieved, they can gain most benefits of the structure without any other burden (such as additional cash outlay). If they only had "significant influence" rather than control, then it would be a different matter.
- Forums
- ASX - By Stock
- AGI
- At least $3.50 if fully T/O
At least $3.50 if fully T/O, page-4
-
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGI (ASX) to my watchlist
|
|||||
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $311.5M |
Open | High | Low | Value | Volume |
93.0¢ | 93.0¢ | 92.0¢ | $1.243K | 1.338K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14945 | 89.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
93.0¢ | 740 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14945 | 0.895 |
1 | 31338 | 0.870 |
1 | 8887 | 0.855 |
1 | 5882 | 0.850 |
1 | 1000 | 0.830 |
Price($) | Vol. | No. |
---|---|---|
0.930 | 740 | 1 |
0.940 | 5577 | 1 |
0.950 | 3739 | 2 |
1.020 | 2499 | 1 |
1.035 | 6785 | 1 |
Last trade - 11.00am 15/07/2024 (20 minute delay) ? |
Featured News
AGI (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online